Compare CNH & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNH | RDY |
|---|---|---|
| Founded | 1842 | 1984 |
| Country | United Kingdom | India |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 11.6B |
| IPO Year | N/A | N/A |
| Metric | CNH | RDY |
|---|---|---|
| Price | $10.70 | $13.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $13.08 | ★ $16.90 |
| AVG Volume (30 Days) | ★ 12.6M | 1.6M |
| Earning Date | 02-17-2026 | 01-20-2026 |
| Dividend Yield | ★ 2.30% | 0.54% |
| EPS Growth | N/A | ★ 5.58 |
| EPS | 0.48 | ★ 0.76 |
| Revenue | ★ $17,814,000,000.00 | $3,848,694,754.00 |
| Revenue This Year | N/A | $6.12 |
| Revenue Next Year | N/A | $2.58 |
| P/E Ratio | $22.71 | ★ $17.53 |
| Revenue Growth | N/A | ★ 11.09 |
| 52 Week Low | $9.00 | $12.26 |
| 52 Week High | $14.27 | $16.17 |
| Indicator | CNH | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 58.53 | 44.44 |
| Support Level | $10.72 | $13.13 |
| Resistance Level | $10.96 | $13.85 |
| Average True Range (ATR) | 0.27 | 0.22 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 55.36 | 48.46 |
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.